Aktuellt
SENASTE
Redeye provides an initial take on SenzaGen’s H1 2023 report. The sales for the first half of the year came in at SEK23.6m, 14% lower than our sales estimate of SEK27.5m. Moreover, EBIT came in at SEK-12.5m, lower than our estimate of SEK-8.5m; however, adjustments for non-cash items were much higher than anticipated. We will provide an update shortly where we expect to make some downward changes to our 2023e estimates; however, we do not expect our fair value range to differ significantly.
LÄS MER
